(Q54251757)

English

Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.

scientific article

Statements

Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit